REVIEW OF INDICATION-BASED PRICING PRACTICE IN SWITZERLAND

被引：0

作者：

Ringger, D. ^{[1
]}

Darlington, O. ^{[2
]}

Mumford, A. ^{[3
]}

机构：

[1] Initiate Consultancy, Zug, Switzerland

[2] Initiate Consultancy, Cardiff, Wales

[3] Initiate Consultancy, Northampton, England

来源：

VALUE IN HEALTH | 2023年 / 26卷 / 06期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

HPR30

引用

页码：S216 / S216

页数：1

共 50 条

[1] Is Indication-Based Drug Pricing Used in Practice?
不详
[J]. PHARMACEUTICAL MEDICINE, 2019, 33 (06) : 538 - 539
[2] Indication-Based Pricing for Multi-Indication Drugs
Adida, Elodie
[J]. MANAGEMENT SCIENCE, 2023, 70 (11) : 7506 - 7523
[3] The Economics of Indication-Based Drug Pricing
Chandra, Amitabh
Garthwaite, Craig
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (02): : 103 - 106
[4] The Role of Indication-Based Pricing in Future Pricing and Reimbursement Policies: A Systematic Review
Preckler, Victor
Espin, Jaime
[J]. VALUE IN HEALTH, 2022, 25 (04) : 666 - 675
[5] ASSESSING THE FEASIBILITY OF IMPLEMENTING INDICATION-BASED PRICING IN SWEDEN: A QUALITATIVE ANALYSIS
Viollet, J.
Williams, I
Zethraeus, N.
[J]. VALUE IN HEALTH, 2022, 25 (12) : S237 - S237
[6] INDICATION-BASED PRICING OF THE PHARMACEUTICALS IN CROATIA: CASE-STUDY MODELLING EXCERCISE
Bobinac, A.
Velic, I
[J]. VALUE IN HEALTH, 2023, 26 (12) : S383 - S383
[7] EXPLORING THE FEASIBILITY OF INDICATION-BASED PRICING IN THE KOREA HEALTHCARE SYSTEM: A SURVEY STUDY
Kim, B. R. M.
Lee, Y. S.
Ahn, S. Y.
Shin, B. R.
Kim, J.
[J]. VALUE IN HEALTH, 2023, 26 (12) : S547 - S547
[8] SHOULD DRUG PRICES DIFFER BY INDICATION? OUTLINING THE DEBATE ON INDICATION-BASED PRICING AND HOW IT HAS BEEN IMPLEMENTED
Chapman, A.
Zamora, B.
Towse, A.
[J]. VALUE IN HEALTH, 2018, 21 : S186 - S186
[9] From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy
Rossini, Elvio Emanuele
Galeone, Carlotta
Lucchetti, Chiara
Jommi, Claudio
[J]. PHARMACOECONOMICS-OPEN, 2024, 8 (02) : 251 - 261
[10] From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy
Elvio Emanuele Rossini
Carlotta Galeone
Chiara Lucchetti
Claudio Jommi
[J]. PharmacoEconomics - Open, 2024, 8 : 251 - 261

← 1 2 3 4 5 →